Evidence map›Paper›PMID 33821680›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2021

Experiences With Smoking Cessation Attempts and Prior Use of Cessation Aids in Smokers With HIV: Findings From a Focus Group Study Conducted in Durham, North Carolina.

Lauren R Pacek, Alicia D Holloway, Karen L Cropsey, Christina S Meade, Maggie M Sweitzer, James M Davis, F Joseph McClernon

Abstract read
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Can We Predict Who Will Experience Adverse Events While Using Smoking Cessation Pharmacotherapy? A Secondary Analysis of the EAGLES Clinical Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lauren R PacekDuke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina.
Alicia D HollowayDuke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina.
Karen L CropseyUniversity of Alabama at Birmingham, Department of Psychiatry and Behavioral Neurobiology, Birmingham, Alabama.
Christina S MeadeDuke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina.
Maggie M SweitzerDuke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina.
James M DavisDuke University School of Medicine, General Internal Medicine, and the Duke Cancer Institute, Durham, North Carolina.
F Joseph McClernonDuke University School of Medicine, Department of Psychiatry and Behavioral Sciences, Durham, North Carolina.

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ARTHUR Y KIM · 2004 to 2026
$94.4M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
Effectiveness of a smoking cessation algorithm integrated into HIV primary careR01DA044112 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CRANE, HEIDI M., CROPSEY, KAREN L · 2018 to 2022
$3.5M
Decision Making and HIV Risk: New Approaches to neuroAIDS Research in Drug UsersDP2DA040226 · NIDA · DUKE UNIVERSITY · PI MEADE, CHRISTINA S · 2015 to 2015
$2.4M
Mobile health interventions for varenicline adherence among HIV-positive smokersK01DA043413 · NIDA · DUKE UNIVERSITY · PI PACEK, LAUREN RENEE · 2017 to 2021
$860k
Targeting reward dysfunction as a mechanism to improve smoking cessationK23DA039294 · NIDA · DUKE UNIVERSITY · PI SWEITZER, MAGGIE M · 2016 to 2020
$817k
NIAID NIH HHS P30 AI060354NIAID NIH HHS P30 AI064518NIDA NIH HHS DP2 DA040226NIDA NIH HHS K01 DA043413NIDA NIH HHS K23 DA039294NIDA NIH HHS R01 DA044112
6 · The paper itself

Abstract

Cigarette smoking remains disproportionately prevalent and is increasingly a cause of death and disability among people with HIV (PWH). Many PWH are interested in quitting, but interest in and uptake of first-line smoking cessation pharmacotherapies are varied in this population. To provide current data regarding experiences with and perceptions of smoking cessation and cessation aids among PWH living in Durham, North Carolina, the authors conducted five focus group interviews (total

Indexed as

AdolescentAdultAgedBlack or African AmericanFemaleFocus GroupsHealth BehaviorHIV InfectionsHumansInterviews as TopicMaleMiddle AgedNorth CarolinaQualitative ResearchSmokersSmoking CessationcessationHIVqualitative researchsmokingtobacco

Identifiers

PMID33821680
PMCPMC8158019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.